Key facts
- Liberate Medical’s last known valuation is $22.7M (Aug 2025).
- It has raised $13.1M across 3 recorded rounds; the latest was Seed Round ($4.5M) in Aug 2025.
- Notable investors include US National Science Foundation, MedTech Innovator, United States Department of War, Texas Medical Center, Keyhorse Capital — 14 tracked in total.
- Liberate Medical has filed 4 Form Ds with the SEC since 2016, most recently Sep 2025 ($4.5M sold to 22 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Liberate Medical
Funding rounds
3 roundsAbout Liberate Medical
Developer of a respiratory muscle stimulator intended to reduce the number of days a patient spends on mechanical ventilation. The company's stimulator uses proprietary non-invasive neuromuscular electrical stimulation to contract the abdominal wall muscles in synchrony with exhalation during mechanical ventilation, enabling hospitals to improve the quality of life and reduce the cost of care for patients with pulmonary disorders.
- Sector
- Healthcare
- HQ
- Crestwood, KY, United States
- Founded
- 2013
- Employees
- 10
- Website
- liberatemedical.com/
- Ownership
- Privately Held (backing)
Liberate Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liberate Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liberate Medical in its N-PORT filings yet. We sweep new filings monthly.